(Q41750388)

8 October 2017

1 reference

title

The classification of calcium antagonists and their selection in the treatment of hypertension. A reappraisal (English)

1 reference

8 October 2017

1

Lüscher TF

1 reference

8 October 2017

Cosentino F

2

1 reference

8 October 2017

publication date

1 April 1998

1 reference

8 October 2017

1 reference

8 October 2017

volume

55

1 reference

8 October 2017

issue

4

1 reference

8 October 2017

page(s)

509-517

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199855040-00003

8 October 2017

exact match

0 references

cites work

Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease

1 reference

12 December 2020

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

12 December 2020

"Cardioprotection"--not all calcium antagonists are created equal: second round

1 reference

12 December 2020

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

1 reference

12 December 2020

Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group

1 reference

12 December 2020

Differential activation of cardiac and peripheral sympathetic nervous system by nifedipine: role of pharmacokinetics

1 reference

12 December 2020

Structure and function of the rat basilar artery during chronic nitric oxide synthase inhibition

1 reference

12 December 2020

Pharmacology of the dihydropyridine calcium antagonists: relationship between lipophilicity and pharmacodynamic responses

1 reference

12 December 2020

The endothelium in hypertension: bystander, target or mediator?

1 reference

12 December 2020

Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

1 reference

12 December 2020

Safety aspects of treatment with lacidipine--a slow-onset, long-acting calcium antagonist

1 reference

12 December 2020

Current issues in treating the hypertensive patient with diabetes: focus on diabetic nephropathy

1 reference

12 December 2020

Blood pressure variability and its implications for antihypertensive therapy

1 reference

12 December 2020

Effect of captopril and enalapril on endothelial function in hypertensive patients.

1 reference

12 December 2020

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis

1 reference

12 December 2020

Classification and tissue selectivity of calcium antagonists

1 reference

12 December 2020

Effects of lacidipine on peak oxygen consumption, neurohormones and invasive haemodynamics in patients with mild to moderate chronic heart failure

1 reference

12 December 2020

Endothelin-1 in pulmonary hypertension associated with high-altitude exposure

1 reference

12 December 2020

Endothelin activates the dihydropyridine-sensitive, voltage-dependent Ca2+ channel in vascular smooth muscle

1 reference

12 December 2020

Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients.

1 reference

12 December 2020

Different Mobilization of Calcium in Endothelin-1 -Induced Contractions in Human Arteries and Veins: Effects of Calcium Antagonists

1 reference

12 December 2020

Third generation calcium antagonists: further developments

1 reference

12 December 2020

Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Danish Verapamil Infarction Trial (DAVIT) Study Group.

1 reference

12 December 2020

Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor

1 reference

12 December 2020

L-NAME hypertension alters endothelial and smooth muscle function in rat aorta. Prevention by trandolapril and verapamil

1 reference

12 December 2020

Third generation calcium entry blockers

1 reference

12 December 2020

Major differences among the three classes of calcium antagonists

1 reference

12 December 2020

Normalization of abnormal coronary vasomotion by calcium antagonists in patients with hypertension

1 reference

12 December 2020

Mechanisms whereby calcium channel antagonists may protect patients with coronary artery disease

1 reference

12 December 2020

Calcium antagonists in cardiovascular disease

1 reference

12 December 2020

The unnecessary controversy

1 reference

12 December 2020

Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies

1 reference

12 December 2020

Calcium-antagonist controversy: the long and short of it?

1 reference

12 December 2020

Clinical relevance of 24 h blood pressure control by 1,4-dihydropyridines

1 reference

12 December 2020

Ascertaining how much compliance is enough with outpatient antibiotic regimens

1 reference

12 December 2020

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

12 December 2020

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

1 reference

12 December 2020

Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension

1 reference

12 December 2020

Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency. Effect of verapamil and trandolapril

1 reference

12 December 2020

Different potency of endothelium-derived relaxing factors against thromboxane, endothelin, and potassium chloride in intramyocardial porcine coronary arteries

1 reference

12 December 2020

A comparative review of the adverse effects of calcium antagonists

1 reference

12 December 2020

Pharmacologic and therapeutic differences among calcium channel antagonists: profile of mibefradil, a new calcium antagonist

1 reference

12 December 2020

1993 guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. Guidelines Sub-Committee

1 reference

12 December 2020

Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension.

1 reference

12 December 2020

Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group

1 reference

12 December 2020

10.2165/00003495-199855040-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

8 October 2017

1043657144

0 references

1 reference